Lymphangioleiomyomatosis: Early Signs, Risk Factors, and How It Is Treated

Lymphangioleiomyomatosis is a rare disease in which abnormal smooth muscle-like cells grow in the lungs and sometimes the kidneys or lymphatic system, leading to lung cysts and breathing problems. Early recognition matters because treatment and follow-up can help slow progression, reduce complications, and support daily quality of life.

Overview

Lymphangioleiomyomatosis is a rare lung disease in which abnormal cells grow in the lungs, lymphatic system, and sometimes the kidneys. These cells can lead to the formation of multiple lung cysts, which may gradually affect breathing and increase the risk of a collapsed lung. Although the name is complex, the central issue is usually ongoing damage to lung tissue that can make everyday activities feel more difficult over time.

This condition is often called LAM. It occurs in two main settings: sporadic LAM, which develops on its own, and LAM associated with tuberous sclerosis complex, a genetic condition that can affect several organs. In both forms, the disease is linked to changes in cell-growth pathways, especially the mTOR pathway, which is why targeted treatment is possible for some people.

LAM most commonly affects women, particularly before menopause, though individual cases vary. Some people are diagnosed after symptoms appear, while others are identified after imaging for a collapsed lung or a kidney growth called an angiomyolipoma. Because the disease is uncommon and symptoms can resemble asthma or other lung disorders, diagnosis is sometimes delayed.

Early signs and symptoms

Early lymphangioleiomyomatosis symptoms are often subtle. A person may notice getting out of breath more easily when climbing stairs, walking uphill, or exercising. A dry cough, mild chest discomfort, fatigue with exertion, or a gradual drop in stamina can also appear before the disease is recognized.

One of the most important early clues is a spontaneous pneumothorax, also called a collapsed lung. This may cause sudden chest pain and shortness of breath, sometimes in an otherwise healthy young or middle-aged woman. Recurrent episodes can happen, and they often prompt further investigation with chest imaging.

Some people also develop symptoms outside the lungs. These may include swelling related to the lymphatic system, fluid around the lungs, or abdominal discomfort from kidney angiomyolipomas. Not everyone has all features, but a pattern of unexplained breathing symptoms together with these findings can point toward LAM.

• Shortness of breath during activity
• Reduced exercise tolerance
• Dry cough
• Chest pain or chest tightness
• Spontaneous collapsed lung
• Less commonly, wheezing, fluid around the lungs, or abdominal symptoms

Why it happens and who is at risk

LAM develops when abnormal smooth muscle-like cells grow and spread within the lungs and related tissues. These cells are associated with changes in genes involved in the mTOR signaling pathway, especially TSC1 and TSC2. When this pathway becomes overactive, cells may grow and survive in ways that lead to cyst formation and damage to normal lung structure.

The condition occurs either sporadically or in association with tuberous sclerosis complex. In people with tuberous sclerosis complex, LAM is one of several possible manifestations and may be found alongside kidney, brain, or skin findings. When a clinician suspects this broader pattern, evaluation may include looking for signs of tuberous sclerosis.

Risk is strongly linked to sex and hormonal factors, since LAM predominantly affects women. Researchers continue to study the role of estrogen and other hormones in disease behavior. Having a history of recurrent pneumothorax, unexplained lung cysts on imaging, or a renal angiomyolipoma can also raise suspicion for LAM, even in someone who has not previously been diagnosed with a genetic syndrome.

How lymphangioleiomyomatosis is diagnosed

Diagnosis usually begins with a careful review of symptoms, medical history, and imaging findings. A high-resolution CT scan of the chest is central because it can show the characteristic pattern of many thin-walled cysts spread through the lungs. This imaging appearance often helps distinguish LAM from other causes of cystic lung disease.

Doctors also use supporting findings to confirm the diagnosis without surgery whenever possible. These may include a history of tuberous sclerosis complex, kidney angiomyolipomas, chylous pleural effusions, or an elevated blood level of vascular endothelial growth factor-D, commonly called VEGF-D. Pulmonary function tests are also important because they show how well the lungs are working and provide a baseline for future follow-up.

In some cases, additional testing is needed if the diagnosis remains uncertain. A clinician may consider bronchoscopy or a lung biopsy, but these are usually reserved for selected situations. Because other diseases can also produce breathlessness or cystic changes, doctors may compare LAM with other interstitial lung disease patterns or structural lung conditions before reaching a final diagnosis.

Treatment options and long-term management

Treatment for lymphangioleiomyomatosis is individualized. The main goals are to slow disease progression, relieve symptoms, prevent complications, and preserve daily function. Follow-up typically includes repeat lung function testing, imaging when needed, and review of symptoms such as shortness of breath, chest pain, or changes in exercise capacity.

For people with declining lung function, problematic symptoms, or certain complications, mTOR inhibitor therapy may be recommended. These medicines can help stabilize lung function and may also reduce the size of associated angiomyolipomas or improve lymphatic complications. When supportive respiratory care is needed, a specialist may advise inhaled medication for selected patients, oxygen therapy, pulmonary rehabilitation, or broader lung disease treatment planning based on symptoms and test results.

Complications are treated directly when they occur. A collapsed lung may require urgent drainage and, in recurrent cases, procedures to reduce the chance of another episode. Kidney angiomyolipomas may need surveillance or treatment depending on their size and symptoms, and some patients benefit from coordinated thoracic surgery evaluation when procedures are necessary. In advanced disease, lung transplant may be considered for carefully selected patients after specialist assessment.

Care often works best when it is multidisciplinary. Pulmonologists, radiologists, thoracic surgeons, nephrologists, and genetic specialists may all contribute, especially when LAM is linked to tuberous sclerosis complex or kidney involvement.

Daily living, prevention, and self-care

There is no known way to fully prevent lymphangioleiomyomatosis, but healthy habits and regular medical follow-up can support lung health. Avoiding smoking is especially important, since smoking can worsen lung injury and complicate breathing problems. Staying up to date with recommended vaccinations, including influenza and other vaccines advised by a clinician, may also help reduce the impact of respiratory infections.

People with LAM often benefit from pacing activities, maintaining physical conditioning within personal limits, and discussing exercise plans with their care team. Pulmonary rehabilitation may help with stamina, breathing techniques, and confidence during daily activity. If oxygen levels are low, prescribed oxygen should be used as directed.

Hormonal issues should be reviewed with a doctor because the disease can be influenced by hormonal factors. Pregnancy planning, contraceptive choices, and use of estrogen-containing therapies should be discussed individually rather than assumed to be safe for everyone. Travel to high altitude or air travel may also deserve personalized advice, particularly for someone with a history of pneumothorax.

Keeping a record of symptoms can be useful. Changes in breathlessness, new chest pain, reduced exercise tolerance, or repeated respiratory infections should be shared during follow-up appointments so treatment can be adjusted if needed.

When to seek medical care

Medical care should be sought promptly for sudden shortness of breath, sudden chest pain, coughing up blood, or symptoms that suggest a collapsed lung. These problems do not always mean an emergency, but they should be assessed quickly because LAM can increase the risk of urgent chest complications.

A planned medical evaluation is also important for ongoing but unexplained symptoms such as gradually worsening breathlessness, repeated wheezing that does not fit typical asthma, recurrent pneumothorax, or a lung CT showing multiple cysts. Early review by a respiratory specialist can help clarify the diagnosis and identify treatment options before more significant loss of lung function occurs.

Near the end of the diagnostic or treatment pathway, some people may choose care in a center with coordinated respiratory, imaging, surgical, and genetic expertise. Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals diagnose and treat complex lung conditions for international patients when this level of evaluation is needed.

Frequently asked questions

Is lymphangioleiomyomatosis cancer?

Lymphangioleiomyomatosis is not usually described as a typical cancer. It is a rare disease involving abnormal cell growth that behaves differently from common lung cancers. Even so, it can cause progressive lung damage and needs specialist follow-up.

Who usually gets lymphangioleiomyomatosis?

LAM mainly affects women, especially during the reproductive years, although it can be diagnosed at different ages. It may occur on its own or together with tuberous sclerosis complex. Because it is rare, many people have never heard of it before diagnosis.

What are the first signs of lymphangioleiomyomatosis?

The earliest signs are often shortness of breath during activity, reduced exercise tolerance, and a dry cough. Some people first learn they have LAM after a sudden collapsed lung causes chest pain and breathlessness. Symptoms can be mild at first and may resemble more common lung problems.

Can lymphangioleiomyomatosis be cured?

There is currently no complete cure for LAM, but treatment can help control symptoms and slow disease progression in many patients. Regular monitoring is important because the condition can change over time. Care plans are tailored to lung function, symptoms, and complications.

How is lymphangioleiomyomatosis treated?

Treatment may include monitoring, mTOR inhibitor therapy, oxygen if needed, pulmonary rehabilitation, and management of complications such as pneumothorax or pleural fluid. Kidney angiomyolipomas and lymphatic problems may also need treatment. The exact approach depends on how active the disease is and which organs are involved.

Is pregnancy possible with lymphangioleiomyomatosis?

Pregnancy may be possible, but it requires careful discussion with a specialist because LAM can be influenced by hormonal factors and complications may occur. Risks differ from person to person depending on lung function, previous pneumothorax, and overall disease stability. Pre-pregnancy counseling is the safest approach.

When should someone with LAM go to the emergency department?

Emergency assessment is important for sudden chest pain, sudden shortness of breath, or signs of a possible collapsed lung. These symptoms should not be ignored, especially in someone with known or suspected LAM. Prompt evaluation can help identify complications and guide treatment quickly.

References

• National Heart, Lung, and Blood Institute
• American Thoracic Society
• European Respiratory Society
• National Organization for Rare Disorders
• Genetic and Rare Diseases Information Center

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.